id,analyte_A260A280Ratio,vital_status,gender,race,ethnicity,disease_type,primary_site,investigation,days_to_death,tissue_source_site_label,country_of_sample_procurement,pathologic_t_label,pathologic_n_label,histological_diagnosis_label,pathologic_stage_label,PlateCenter,PlateCenterFlag,observed_otus
13722.58cfa82de4b0c9d6adf6a4c2,NA,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,2361,Duke,United States,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A21Q-09,TRUE,12
13722.58cfa82de4b0c9d6adf6a4ce,2.08,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,MSKCC,None,T3,N2,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,28
13722.58cfa82de4b0c9d6adf6a48a,2.18,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A066-09,TRUE,72
13722.58cfa82de4b0c9d6adf6a4d4,1.85,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A066-09,TRUE,81
13722.58cfa82de4b0c9d6adf6a529,2,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A127-09,FALSE,26
13722.58cfa82de4b0c9d6adf6a46d,1.93,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,1142,University of Pittsburgh,None,T2b,N1,Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,54
13722.58cfa82de4b0c9d6adf6a52c,1.89,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Indivumed,Germany,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,83
13722.58cfa82de4b0c9d6adf6a542,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A325-09,TRUE,22
13722.58cfa82de4b0c9d6adf6a59b,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,MD Anderson,United States,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A22X-09,FALSE,11
13722.58cfa82de4b0c9d6adf6a548,2.23,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Indivumed,Germany,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB,A19H-09,TRUE,62
13722.58cfa82de4b0c9d6adf6a5a6,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A29N-09,FALSE,16
13722.58cfa82de4b0c9d6adf6a59d,2.03,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,1484,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A066-09,TRUE,46
13722.58cfa82de4b0c9d6adf6a546,2,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A013-09,TRUE,66
13722.58cfa82de4b0c9d6adf6a572,1.88,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,UCSF,United States,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,10
13722.58cfa82de4b0c9d6adf6a5f2,2.02,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Pittsburgh,None,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A12B-09,FALSE,11
13722.58cfa82de4b0c9d6adf6a656,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,United States,T2,N1a,Infiltrating Lobular Carcinoma,Stage IIB,A20S-09,FALSE,9
13722.58cfa82de4b0c9d6adf6a610,1.95,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,348,Medical College of Wisconsin,United States,T1b,N1,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,20
13722.58cfa82de4b0c9d6adf6a624,1.94,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University of North Carolina,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A13L-09,FALSE,71
13722.58cfa82de4b0c9d6adf6a60e,1.85,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Indivumed,Germany,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,19
13722.58cfa82de4b0c9d6adf6a676,1.95,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,669,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A013-09,TRUE,44
13722.58cfa82de4b0c9d6adf6a6c0,2.13,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A14K-09,FALSE,69
13722.58cfa82de4b0c9d6adf6a6d6,1.82,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,636,Medical College of Wisconsin,United States,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,19
13722.58cfa82de4b0c9d6adf6a6ec,2.02,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Mayo,None,T1,N1,Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,16
13722.58cfa82de4b0c9d6adf6a70c,1.91,Dead,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,570,Medical College of Wisconsin,United States,TX,N0,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,58
13722.58cfa82de4b0c9d6adf6a6e0,1.95,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,101
13722.58cfa83ce4b0c9d6adf72e98,1.93,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,United States,T3,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A142-09,FALSE,12
13722.58cfa83ce4b0c9d6adf72fd0,1.81,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A122-09,TRUE,28
13722.58cfa83ce4b0c9d6adf72e96,2.08,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Indivumed,Germany,T1c,N1,Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,13
13722.58cfa83ce4b0c9d6adf72fd8,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Gynecologic Oncology Group,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A135-09,FALSE,13
13722.58cfa83ce4b0c9d6adf72ee6,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Gynecologic Oncology Group,United States,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A18J-09,TRUE,43
13722.58cfa83ce4b0c9d6adf730f0,2,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A066-09,TRUE,42
13722.58cfa83ce4b0c9d6adf72f94,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A013-09,TRUE,14
13722.58cfa83ce4b0c9d6adf73120,1.84,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Miami,United States,T3,N0 (i-),Infiltrating Lobular Carcinoma,Stage IIB,A13L-09,FALSE,13
13722.58cfa83ce4b0c9d6adf730e8,2.08,Alive,FEMALE,Not available,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University Health Network,Canada,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A159-09,FALSE,44
13722.58cfa83ce4b0c9d6adf72ea6,2,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,1106,MSKCC,None,Not available,Not available,Mixed serous and endometrioid,Not available,A066-09,TRUE,64
13722.58cfa83ce4b0c9d6adf731a2,1.91,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MD Anderson,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A34H-09,TRUE,30
13722.58cfa83ce4b0c9d6adf73074,1.97,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,ILSbio,None,T1,N2,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,37
13722.58cfa83ce4b0c9d6adf7310e,1.97,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,ILSbio,Vietnam,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,15
13722.58cfa82de4b0c9d6adf6a44c,1.86,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Asterand,Russia,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB,A14G-09,FALSE,9
13722.58cfa82de4b0c9d6adf6a49a,1.97,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB,A19H-09,TRUE,57
13722.58cfa82de4b0c9d6adf6a4be,1.93,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A013-09,TRUE,10
13722.58cfa82de4b0c9d6adf6a47a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Gynecologic Oncology Group,United States,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available,A34H-09,TRUE,23
13722.58cfa82de4b0c9d6adf6a4e6,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A228-09,FALSE,22
13722.58cfa82de4b0c9d6adf6a514,2.26,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,361,Duke,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A142-09,FALSE,12
13722.58cfa82de4b0c9d6adf6a522,1.77,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,3472,University of Pittsburgh,None,T1c,N1b,Medullary Carcinoma,Stage IIA,A13L-09,FALSE,18
13722.58cfa82de4b0c9d6adf6a51c,1.93,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,1563,University of Pittsburgh,None,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,27
13722.58cfa82de4b0c9d6adf6a535,2,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB,A314-09,TRUE,12
13722.58cfa82de4b0c9d6adf6a53a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,International Genomics Consortium,United States,Not available,Not available,Not available,Not available,A228-09,FALSE,14
13722.58cfa82de4b0c9d6adf6a570,1.95,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Gynecologic Oncology Group,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A34H-09,TRUE,23
13722.58cfa82de4b0c9d6adf6a4e2,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Gynecologic Oncology Group,United States,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available,A34H-09,TRUE,94
13722.58cfa82de4b0c9d6adf6a599,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,ABS - IUPUI,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,11
13722.58cfa82de4b0c9d6adf6a58f,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Not available,United States,T2,N0 (i+),Infiltrating Ductal Carcinoma,Stage IIA,A128-09,TRUE,23
13722.58cfa82de4b0c9d6adf6a5b3,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A228-09,FALSE,19
13722.58cfa82de4b0c9d6adf6a5b2,1.95,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,MSKCC,None,T2,N0 (i-),Other  specify,Stage IIA,A10Y-09,FALSE,20
13722.58cfa82de4b0c9d6adf6a5ce,2.13,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A122-09,TRUE,22
13722.58cfa82de4b0c9d6adf6a618,1.93,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Miami,United States,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A17G-09,FALSE,9
13722.58cfa82de4b0c9d6adf6a60c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,13
13722.58cfa82de4b0c9d6adf6a61e,1.73,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,166,Medical College of Wisconsin,United States,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,18
13722.58cfa82de4b0c9d6adf6a65e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,17
13722.58cfa82de4b0c9d6adf6a640,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,295,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,13
13722.58cfa82de4b0c9d6adf6a674,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A29N-09,FALSE,18
13722.58cfa82de4b0c9d6adf6a68a,1.87,Dead,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,426,Indivumed,Germany,T2,N3a,Infiltrating Lobular Carcinoma,Stage IIIC,A19H-09,TRUE,48
13722.58cfa82de4b0c9d6adf6a65f,2,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A122-09,TRUE,14
13722.58cfa82de4b0c9d6adf6a6d4,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,ABS - IUPUI,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,12
13722.58cfa82de4b0c9d6adf6a6da,NA,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,ILSbio,Vietnam,Not available,Not available,Not available,Not available,A24N-09,TRUE,20
13722.58cfa830e4b0c9d6adf6bb98,1.91,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A128-09,TRUE,31
13722.58cfa83ce4b0c9d6adf72ea0,2.03,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,709,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A066-09,TRUE,13
13722.58cfa83ce4b0c9d6adf72eb0,1.75,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Greater Poland Cancer Center,Poland,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A16D-09,FALSE,14
13722.58cfa83ce4b0c9d6adf72edb,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Miami,United States,T3,N1a,Infiltrating Ductal Carcinoma,Stage IIIA,A228-09,FALSE,9
13722.58cfa83ce4b0c9d6adf72ed8,NA,Dead,FEMALE,WHITE,Not available,Sarcoma,Mesenchymal,TCGA-SARC,180,Cedars Sinai,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,12
13722.58cfa83ce4b0c9d6adf72ef4,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A27P-09,FALSE,15
13722.58cfa83ce4b0c9d6adf72f0d,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,564,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,12
13722.58cfa83ce4b0c9d6adf72f45,1.82,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A26G-09,FALSE,19
13722.58cfa83ce4b0c9d6adf72f2c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,15
13722.58cfa83ce4b0c9d6adf72f7b,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,767,University of Texas MD Anderson Cancer Center,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,13
13722.58cfa83ce4b0c9d6adf72f7f,2.41,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A122-09,TRUE,17
13722.58cfa83ce4b0c9d6adf72f9a,1.93,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Mayo,United States,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A314-09,TRUE,35
13722.58cfa83ce4b0c9d6adf72f73,1.96,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,ILSbio,Vietnam,T3,N2,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,25
13722.58cfa83ce4b0c9d6adf72fb2,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Mayo,United States,T3,N2,Infiltrating Lobular Carcinoma,Stage III,A17W-09,FALSE,11
13722.58cfa82de4b0c9d6adf6a45b,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,413,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,20
13722.58cfa83ce4b0c9d6adf730ac,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,ABS - IUPUI,United States,T3,N0,Infiltrating Ductal Carcinoma,Stage IIB,A21Q-09,TRUE,12
13722.58cfa83ce4b0c9d6adf730ed,1.92,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Duke,United States,T3,N1b,Infiltrating Ductal Carcinoma,Stage IIIA,A128-09,TRUE,9
13722.58cfa83ce4b0c9d6adf730e0,1.86,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A066-09,TRUE,33
13722.58cfa83ce4b0c9d6adf730fa,1.88,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T1,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA,A128-09,TRUE,38
13722.58cfa83ce4b0c9d6adf730c0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,International Genomics Consortium,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,16
13722.58cfa83ce4b0c9d6adf7313a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Cedars Sinai,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,17
13722.58cfa83ce4b0c9d6adf73142,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,275,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,20
13722.58cfa83ce4b0c9d6adf731d0,NA,Dead,MALE,Not available,Not available,Sarcoma,Mesenchymal,TCGA-SARC,138,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A29N-09,FALSE,17
13722.58cfa83ce4b0c9d6adf731b8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,23
13722.58cfa83ce4b0c9d6adf7308c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,14
13722.58cfa83ce4b0c9d6adf73082,1.98,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Medical College of Wisconsin,United States,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,10
13722.58cfa82de4b0c9d6adf6a464,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,International Genomics Consortium,None,Not available,Not available,Not available,Not available,A21Q-09,TRUE,29
13722.58cfa82de4b0c9d6adf6a444,1.86,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Pittsburgh,None,T1c,N0,Infiltrating Ductal Carcinoma,Stage I,A10Y-09,FALSE,8
13722.58cfa82de4b0c9d6adf6a4a6,2.18,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Miami,United States,T3,N1a,Infiltrating Ductal Carcinoma,Stage IIIA,A142-09,FALSE,9
13722.58cfa82de4b0c9d6adf6a4a8,1.56,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,266,Roswell Park,United States,T4b,N3a,Infiltrating Ductal Carcinoma,Stage IIIC,A14G-09,FALSE,26
13722.58cfa82de4b0c9d6adf6a50c,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,None,T1c,N0,Infiltrating Ductal Carcinoma,Stage I,A314-09,TRUE,10
13722.58cfa82de4b0c9d6adf6a50e,1.97,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Cureline,None,T2,N2,Infiltrating Ductal Carcinoma,Stage IIIA,A10G-09,FALSE,14
13722.58cfa82de4b0c9d6adf6a52e,2,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,United States,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage I,A314-09,TRUE,13
13722.58cfa82de4b0c9d6adf6a526,2.08,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,None,T1c,N1mi,Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,25
13722.58cfa82de4b0c9d6adf6a53c,1.83,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,United States,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB,A167-09,FALSE,44
13722.58cfa82de4b0c9d6adf6a47e,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,14
13722.58cfa82de4b0c9d6adf6a471,1.89,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Gynecologic Oncology Group,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A135-09,FALSE,15
13722.58cfa82de4b0c9d6adf6a56a,1.95,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,239,University of Miami,United States,T2,N3b,Infiltrating Ductal Carcinoma,Stage IIIC,A142-09,FALSE,21
13722.58cfa82de4b0c9d6adf6a58a,1.91,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,1065,Medical College of Wisconsin,United States,T3b,N1,Endocervical Type of Adenocarcinoma,Not available,A200-09,TRUE,15
13722.58cfa82de4b0c9d6adf6a591,2.03,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,991,University of Pittsburgh,None,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A314-09,TRUE,16
13722.58cfa82de4b0c9d6adf6a5b8,1.97,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,None,T2,N2,Infiltrating Ductal Carcinoma,Stage IIIA,A10Y-09,FALSE,15
13722.58cfa82de4b0c9d6adf6a596,1.84,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Cedars Sinai,United States,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,14
13722.58cfa82de4b0c9d6adf6a5c6,1.86,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Medical College of Wisconsin,United States,T1b,N0,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,12
13722.58cfa82de4b0c9d6adf6a614,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,MD Anderson,United States,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A17W-09,FALSE,11
13722.58cfa82de4b0c9d6adf6a63e,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Miami,United States,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB,A21Q-09,TRUE,10
13722.58cfa82de4b0c9d6adf6a65c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,11
13722.58cfa82de4b0c9d6adf6a642,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,None,T2,N3,Infiltrating Ductal Carcinoma,Stage IIIC,A19H-09,TRUE,11
13722.58cfa82de4b0c9d6adf6a69e,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Medical College of Wisconsin,United States,T1b,N0,Cervical Squamous Cell Carcinoma,Not available,A18J-09,TRUE,14
13722.58cfa82de4b0c9d6adf6a658,2.09,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A10B-09,TRUE,65
13722.58cfa82de4b0c9d6adf6a6c4,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Gynecologic Oncology Group,United States,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A18J-09,TRUE,64
13722.58cfa82de4b0c9d6adf6a6bc,2.06,Dead,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,304,Indivumed,Germany,T3,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A19H-09,TRUE,29
13722.58cfa82de4b0c9d6adf6a530,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A10B-09,TRUE,12
13722.58cfa82de4b0c9d6adf6a708,2,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Roswell Park,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A142-09,FALSE,47
13722.58cfa82de4b0c9d6adf6a484,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,427,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,26
13722.58cfa83ce4b0c9d6adf72e9c,1.81,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A10M-09,FALSE,31
13722.58cfa83ce4b0c9d6adf72ea2,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,United States,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A23C-09,FALSE,18
13722.58cfa83ce4b0c9d6adf72eac,1.98,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,543,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A066-09,TRUE,42
13722.58cfa83ce4b0c9d6adf72ef8,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,International Genomics Consortium,United States,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A314-09,TRUE,11
13722.58cfa83ce4b0c9d6adf72f7d,1.91,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Mayo,None,T1,N0,Infiltrating Ductal Carcinoma,Stage I,A12Q-09,FALSE,56
13722.58cfa83ce4b0c9d6adf72f43,1.91,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,United States,T2,N0,Infiltrating Lobular Carcinoma,Stage IIA,A14K-09,FALSE,14
13722.58cfa83ce4b0c9d6adf72fae,NA,Alive,FEMALE,WHITE,Not available,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,15
13722.58cfa83ce4b0c9d6adf72fc8,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,International Genomics Consortium,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,16
13722.58cfa83ce4b0c9d6adf72fec,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,University of North Carolina,United States,Not available,Not available,Not available,Not available,A24N-09,TRUE,14
13722.58cfa83ce4b0c9d6adf72f9e,2,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Christiana Healthcare,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A013-09,TRUE,39
13722.58cfa83ce4b0c9d6adf72f72,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Roswell Park,None,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,28
13722.58cfa83ce4b0c9d6adf7307f,1.86,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Christiana Healthcare,None,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A12Q-09,FALSE,18
13722.58cfa83ce4b0c9d6adf730cb,1.86,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Pittsburgh,None,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A12Q-09,FALSE,9
13722.58cfa83ce4b0c9d6adf7309a,1.91,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,University of Pittsburgh,None,T1c,N0,Infiltrating Ductal Carcinoma,Stage I,A10Y-09,FALSE,39
13722.58cfa83ce4b0c9d6adf73184,1.87,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A10B-09,TRUE,17
13722.58cfa83ce4b0c9d6adf73156,1.83,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A10B-09,TRUE,25
13722.58cfa83ce4b0c9d6adf730d4,1.9,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,653,Duke,United States,T3,N1b,Other  specify,Stage IIIA,A10G-09,FALSE,13
13722.58cfa83ce4b0c9d6adf73060,2.05,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,None,T2,N3a,Infiltrating Ductal Carcinoma,Stage IIIC,A19H-09,TRUE,46
13722.58cfa83ce4b0c9d6adf731cc,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A27P-09,FALSE,16
13722.58cfa83ce4b0c9d6adf72fea,2.05,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Indivumed,Germany,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A19H-09,TRUE,50
13722.58cfa83ce4b0c9d6adf72f14,2.13,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,1016,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A066-09,TRUE,28
13722.58cfa82de4b0c9d6adf6a461,1.97,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,1083,Medical College of Wisconsin,United States,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,81
13722.58cfa82de4b0c9d6adf6a48c,1.84,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Christiana Healthcare,United States,T2,N0 (i+),Other  specify,Stage IIA,A167-09,FALSE,19
13722.58cfa82de4b0c9d6adf6a4b4,1.91,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,146,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A10B-09,TRUE,52
13722.58cfa82de4b0c9d6adf6a4ea,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Walter Reed,United States,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB,A23C-09,FALSE,6
13722.58cfa82de4b0c9d6adf6a510,NA,Alive,FEMALE,Not available,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Ontario Institute for Cancer Research,Canada,T1b,N1,Cervical Squamous Cell Carcinoma,Not available,A18J-09,TRUE,42
13722.58cfa82de4b0c9d6adf6a64a,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Medical College of Wisconsin,United States,T1b,N1,Cervical Squamous Cell Carcinoma,Not available,A18J-09,TRUE,17
13722.58cfa82de4b0c9d6adf6a6fa,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Duke,United States,T3,N1,Infiltrating Ductal Carcinoma,Stage IIIA,A128-09,TRUE,48
13722.58cfa82de4b0c9d6adf6a5ee,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,MSKCC,None,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA,A19H-09,TRUE,30
13722.58cfa82de4b0c9d6adf6a4d6,2,Alive,FEMALE,Not available,HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,MSKCC,None,T2,N1,Infiltrating Ductal Carcinoma,Stage IIB,A19H-09,TRUE,15
13722.58cfa83ce4b0c9d6adf730b4,1.95,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Duke,United States,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB,A128-09,TRUE,49
13722.58cfa82de4b0c9d6adf6a534,NA,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A013-09,TRUE,20
13722.58cfa82de4b0c9d6adf6a577,1.76,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Medical College of Wisconsin,United States,T2b,N0,Cervical Squamous Cell Carcinoma,Not available,A200-09,TRUE,43
13722.58cfa82de4b0c9d6adf6a666,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,NA,Memorial Sloan Kettering,United States,Not available,Not available,Not available,Not available,A21Q-09,TRUE,22
13722.58cfa82fe4b0c9d6adf6b8e0,1.89,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Christiana Healthcare,None,T2,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIA,A12L-09,FALSE,57
13722.58cfa83ce4b0c9d6adf72efc,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Sarcoma,Mesenchymal,TCGA-SARC,384,University of North Carolina,United States,Not available,Not available,Not available,Not available,A29N-09,FALSE,20
13722.58cfa83ce4b0c9d6adf73090,1.93,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,Uterus,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A066-09,TRUE,43